RESEARCH
Genetic Changes Between Primary and Recurrent Rectal Cancer May Reveal New Treatment TargetsA study of 15 matched pairs of primary and locally recurrent rectal cancers found that recurrent tumors acquired new genetic alterations not present in the original tumor, including potentially actionable mutations in genes like KRAS, PIK3CA, MET, and FGFR. (Journal of Gastroenterology)